Whanin Pharm
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, an… Read more
Whanin Pharm (016580) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.013x
Based on the latest financial reports, Whanin Pharm (016580) has a cash flow conversion efficiency ratio of 0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.05 Billion) by net assets (₩393.81 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Whanin Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Whanin Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Whanin Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Whanin Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CYGAM Energy Inc.
V:CYG
|
N/A |
|
Ensurge Micropower ASA
OTCQB:ENMPF
|
-0.318x |
|
Hindware Home Innovation Limited
NSE:HINDWAREAP
|
0.082x |
|
mPLUS Corp
KQ:259630
|
0.299x |
|
Malayan Flour Mills Bhd
KLSE:3662
|
0.098x |
|
Nordic Mining ASA
OL:NOM
|
-0.323x |
|
Synchronoss Technologies Inc
NASDAQ:SNCR
|
0.711x |
|
Ching Feng Home Fashions Co Ltd
TW:9935
|
0.079x |
Annual Cash Flow Conversion Efficiency for Whanin Pharm (2009–2024)
The table below shows the annual cash flow conversion efficiency of Whanin Pharm from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩376.00 Billion | ₩20.69 Billion | 0.055x | -15.01% |
| 2023-12-31 | ₩358.21 Billion | ₩23.20 Billion | 0.065x | +28.33% |
| 2022-12-31 | ₩333.93 Billion | ₩16.85 Billion | 0.050x | -54.67% |
| 2021-12-31 | ₩317.23 Billion | ₩35.32 Billion | 0.111x | +45.12% |
| 2020-12-31 | ₩296.60 Billion | ₩22.75 Billion | 0.077x | -14.86% |
| 2019-12-31 | ₩274.46 Billion | ₩24.73 Billion | 0.090x | +34.01% |
| 2018-12-31 | ₩259.58 Billion | ₩17.45 Billion | 0.067x | -30.39% |
| 2017-12-31 | ₩243.08 Billion | ₩23.48 Billion | 0.097x | +7.26% |
| 2016-12-31 | ₩220.13 Billion | ₩19.82 Billion | 0.090x | -30.67% |
| 2012-12-31 | ₩162.53 Billion | ₩21.11 Billion | 0.130x | +28.78% |
| 2011-12-31 | ₩149.85 Billion | ₩15.12 Billion | 0.101x | -41.22% |
| 2009-12-31 | ₩108.44 Billion | ₩18.61 Billion | 0.172x | -- |